HomeLCTX • NYSEAMERICAN
add
Lineage Cell Therapeutics Inc
$0.58
Pre-market:(5.24%)-0.030
$0.55
Sarado: Ene 13, 4:33:35 AM GMT-5 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$0.53
Sakop ng araw
$0.51 - $0.58
Sakop ng taon
$0.48 - $1.61
Market cap
128.37M USD
Average na Volume
3.17M
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 3.78M | 203.29% |
Gastos sa pagpapatakbo | 4.41M | 9.13% |
Net na kita | -3.03M | 57.33% |
Net profit margin | -80.29 | 85.93% |
Kita sa bawat share | -0.02 | 50.37% |
EBITDA | -3.70M | 43.35% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 32.71M | -20.86% |
Kabuuang asset | 96.59M | -9.00% |
Kabuuang sagutin | 31.80M | -19.48% |
Kabuuang equity | 64.79M | — |
Natitirang share | 188.84M | — |
Presyo para makapag-book | 1.52 | — |
Return on assets | -9.63% | — |
Return on capital | -13.98% | — |
Cash Flow
Net change in cash
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -3.03M | 57.33% |
Cash mula sa mga operasyon | -5.79M | -14.89% |
Cash mula sa pag-invest | 3.89M | 83.22% |
Cash mula sa financing | -3.00K | -100.37% |
Net change in cash | -1.86M | 23.86% |
Malayang cash flow | -2.27M | 12.27% |
Tungkol
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Itinatag
1990
Website
Mga Empleyado
72